v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Revenue $ 388,654 $ 265,481 $ 821,398 $ 745,530
Cost of goods sold 326,671 202,029 645,463 577,539
Gross profit 61,983 63,452 175,935 167,991
Operating expenses:        
Research and development 664,145 297,680 999,449 780,605
Sales and marketing 304,880 432,275 863,400 932,902
General and administrative 1,482,018 1,411,376 3,445,749 3,437,176
Total operating expenses 2,451,043 2,141,331 5,308,598 5,150,683
Loss from operations (2,389,060) (2,077,879) (5,132,663) (4,982,692)
Other (expense) income:        
Other income 17,503 1,142 17,523 1,198
Interest expense (95,469) (65,103) (324,670) (233,084)
Loss on extinguishment of debt (213,700) (566,925)
Other (expense) income, net (291,666) (63,961) (874,072) (231,886)
Net loss (2,680,726) (2,141,840) (6,006,735) (5,214,578)
Deemed dividend on modification of Series H-5 warrants (432,727) (432,727)
Net loss Attributable to Common Stockholders $ (3,113,453) $ (2,141,840) $ (6,439,462) $ (5,214,578)
Net loss per share, basic and diluted $ (0.13) $ (0.77) $ (0.54) $ (1.8)
Basic and diluted weighted average Common Stock outstanding 23,599,967 2,793,592 11,896,906 2,894,374

Source